The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants

Michal Ariela Raz, Jon Arnason, Osnat Bairey, Lev Shvidel, Ariel Aviv, Sharon Ben Baruch, Chava Perry, Nadav Sarid, Ilya Kirgner, Varon Dvid, Yair Herishanu, Irit Avivi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e31-e33
JournalBritish Journal of Haematology
Volume189
Issue number2
DOIs
StatePublished - 1 Apr 2020

Keywords

  • bleeding risk
  • direct oral anticoagulants
  • ibrutinib

Cite this